Article

Hydroxypropyl-β-cyclodextrin-complexed resveratrol protects A53T transgenic Parkinson’s disease mice via modulating signaling pathways of the microbiota-gut-brain axis

2023-05-22

Abstract excerpt

<h4>Background: </h4> Parkinson's disease (PD) is a neurological disorder characterized by motor and gastrointestinal dysfunctions. There is a significant need for more effective treatment options. Resveratrol (RES) is a potent antioxidant and anti-inflammatory phytoalexin known for its health-promoting benefits. However, little is known about its potential in treating PD by modulating the microbial gut-brain axis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6e33c56b-dc1c-599b-b369-60476e816e3d
DOI: 10.21203/rs.3.rs-2950114/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hydroxypropyl-β-cyclodextrin-complexed resveratrol protects A53T transgenic Parkinson’s disease mice via modulating signaling pathways of the microbiota-gut-brain axisDOI 10.21203/rs.3.rs-2950114/v1Read

Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s diseaseSemantic proximity Read

Role of the Microbiota-Metabolite Axis in the Rotenone Model of Early-Stage Parkinson's DiseaseSemantic proximity Read

A review of studies on gut microbiota and levodopa metabolismSemantic proximity Read

Alterations of gut microbiota and metabolome with Parkinson's diseaseSemantic proximity Read

α-synuclein overexpression and the microbiome shape the gut and brain metabolome in miceSemantic proximity Read

Wu Mei Pill Mitigates Dopaminergic Neuron Damage-Induced Parkinson's Disease in Mice Through Modulation of the Gut-Brain-Microbiota AxisSemantic proximity Read

Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and BeyondSemantic proximity Read

α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in MiceSemantic proximity Read

MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson’s diseaseSemantic proximity Read

Soy isoflavones mitigate atrazine-induced dopaminergic neuron damage via reshaping short-chain fatty acid-producing bacteria in gut microbiota and modulating the GPR43/GLP-1/GLP-1R axisSemantic proximity Read

Gut-Brain Axis and Parkinson's Disease: The Role of Small Intestinal Microbiota from Symptom Onset to Therapeutic PerspectivesSemantic proximity Read

Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axisSemantic proximity Read